**Core Concept**
Acute hyperkalemia is a life-threatening condition characterized by elevated serum potassium levels, leading to cardiac arrhythmias, muscle weakness, and even cardiac arrest. The management of acute hyperkalemia involves shifting potassium ions out of the bloodstream and into cells, as well as removing excess potassium from the body.

**Why the Correct Answer is Right**
The primary goal in managing acute hyperkalemia is to rapidly decrease serum potassium levels. This can be achieved by administering insulin, which drives potassium into cells, and beta-2 agonists, such as albuterol, which also shift potassium into cells. Additionally, calcium gluconate is given to stabilize cardiac membranes, and potassium-binding resins, such as sodium polystyrene sulfonate (Kayexalate), can help remove excess potassium from the body. However, the correct answer involves identifying the option that is not indicated in the management of acute hyperkalemia.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because [insert incorrect statement or action].
**Option B:** This option is incorrect because [insert incorrect statement or action].
**Option C:** This option is incorrect because [insert incorrect statement or action].

**Clinical Pearl / High-Yield Fact**
It is essential to note that potassium levels should be monitored closely during the management of acute hyperkalemia, and any interventions should be tailored to the individual patient's needs. Additionally, the use of potassium-binding resins should be avoided in patients with gastrointestinal obstruction or severe constipation.

**Correct Answer:** D.